Incomplete inactivation of voltage-dependent K+ channels in human B lymphoma cells.
The voltage-dependent K (KV) channel in Daudi human B lymphoma cells was characterized by using patch-clamp techniques. Whole-cell voltage-clamp experiments demonstrated that cell membrane depolarization induced a transient (time-dependent) outward current followed by a steady-state (time-independent) component. The time-dependent current resembled behavior of the type n channel, such as use dependence and a unique blockade by tetraethylammonium (TEA). Both time-dependent and time-independent currents were blocked by quinine with a similar IC50 (14.2 mM and 12.6 mM). Treatment with antisense oligonucleotide of human Kv1.3 gene significantly reduced both currents by 80%. Single-channel experiments showed that only one type of KV channel was recorded with a unitary conductance of approximately 19 pS. Consistent with whole-cell recordings, the channel activity in cell-attached patches remained in response to prolonged depolarization, and the remaining channel activity was blocked by quinine, but not TEA. Channel activity was scarcely seen in cell-attached patches after antisense treatment. Whole-cell current-clamp data showed that TEA, which blocks only the time-dependent current, caused a slight decrease in the membrane potential. In contrast, quinine and antisense, which block both time-dependent and -independent currents, strongly reduced the membrane potential. These data together suggest that the KV channel in Daudi cells does not completely inactivate and that the remaining channel activity due to this incomplete inactivation appears to be primarily responsible for maintaining the membrane potential.
Zhou
Z-H
ZH
Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, 1530 Third Avenue South, Birmingham, Alabama 35294, USA.
Unlap
T
T
Li
L
L
Ma
H-P
HP
D004553:Electric Conductivity; D004594:Electrophysiology; D006801:Humans; D016393:Lymphoma, B-Cell / Q000378:metabolism*; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D018408:Patch-Clamp Techniques; D026902:Potassium Channel Blockers / Q000494:pharmacology; D024642:Potassium Channels, Voltage-Gated / Q000187:drug effects* / Q000502:physiology*; D011189:Potassium Chloride / Q000494:pharmacology; D011803:Quinine / Q000494:pharmacology; D012016:Reference Values; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D012965:Sodium Chloride / Q000494:pharmacology; D019789:Tetraethylammonium / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D016376:Oligonucleotides, Antisense; D026902:Potassium Channel Blockers; D024642:Potassium Channels, Voltage-Gated; D012965:Sodium Chloride; D019789:Tetraethylammonium; D011189:Potassium Chloride; D011803:Quinine